Metabolomic Diagnostics - About the company
Metabolomic Diagnostics is a seed company based in Cork (Ireland), founded in 2011. It operates as a Diagnostics and prognostics for maternal health using metabolomics,. Metabolomic Diagnostics has raised $3.89M in funding. The company has 26 active competitors, including 13 that are funded. Its top competitors include companies like Celmatix, Lorven Biologics and Renegade.
Company Details
Metabolomic Diagnostics develops diagnostics and prognostics for maternal health using metabolic profiling. The company is currently developing an early pregnancy test to identify a woman's risk of developing pre-eclampsia later in her pregnancy by testing a panel of implicated metabolites. Metabolomic Diagnostics also has a subsidiary called Inform Bioscience.
- Website
- metabolomicdiagnostics.com
Key Metrics
Founded Year
2011
Location
Cork, Ireland
Stage
Seed
Total Funding
$3.89M in 7 rounds
Latest Funding Round
Investors
Ranked
7th among 26 active competitors
Employee Count
9 as on Mar 31, 2026
Sign up to download Metabolomic Diagnostics' company profile
Metabolomic Diagnostics's funding and investors
Metabolomic Diagnostics has raised a total funding of $3.89M over 7 rounds. Its first funding round was on Jan 03, 2014. Its latest funding round was a Grant (prize money) round on Jan 31, 2021 for $*****. 1 investor participated in its latest round. Metabolomic Diagnostics has 6 institutional investors.
Here is the list of recent funding rounds of Metabolomic Diagnostics:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 31, 2021 | 7107686 | Grant (prize money) | 8250796 | 8050331 | 5991829 | 8104503 |
Nov 01, 2018 | 9776639 | Grant (prize money) | 5128498 | 6745871 | 3712347 | |
Jun 01, 2018 | 1849960 | Grant (prize money) | 5070897 | 3626283 | 4609384 |
View details of Metabolomic Diagnostics's funding rounds and investors
Metabolomic Diagnostics' founders and board of directors
Founder? Claim ProfileMetabolomic Diagnostics' employee count trend
Metabolomic Diagnostics has 9 employees as of Mar 26. Here is Metabolomic Diagnostics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Metabolomic Diagnostics's Competitors and alternates
Top competitors of Metabolomic Diagnostics include Celmatix, Lorven Biologics and Renegade. Here is the list of Top 10 competitors of Metabolomic Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Celmatix 2009, New York City (United States), Series C | Pioneering ovarian health therapeutics for women's unique biological needs | $24.9M | 49/100 | |
2nd | Lorven Biologics 2015, Hyderabad (India), Seed | Developer of nutritional and pharma products | $46.6K | 39/100 | |
3rd | Renegade 2020, San Francisco (United States), Funding Raised | Developer of diagnostic testing for the detection of novel infectious diseases | - | 38/100 | |
4th | LIA Diagnostics 2015, Philadelphia (United States), Seed | Disposable paper pregnancy test kits | $4.22M | 37/100 | |
5th | bluDiagnostics 2015, Madison (United States), Seed | Saliva-based fertility tests for women | $1.15M | - | 36/100 |
6th | adyn 2019, Seattle (United States), Seed | Provider of DNA and hormone analysis based birth control optimization kits | $2.65M | 36/100 | |
7th | Metabolomic Diagnostics 2011, Cork (Ireland), Seed | Diagnostics and prognostics for maternal health using metabolomics, | $3.89M | 34/100 | |
8th | Milu Labs 2018, New York City (United States), Seed | Provider of exosome based diagnostic products | - | 33/100 | |
9th | Next-generation sequencing integration services for assisted pregnancy | $14.3M | 32/100 | ||
10th | Confer Health 2015, Boston (United States), Series A | Clinical-grade at-home health testing kits with fast, actionable results | $9.5M | 30/100 |
Looking for more details on Metabolomic Diagnostics's competitors? Click here to see the top ones
Metabolomic Diagnostics's Investments and acquisitions
Metabolomic Diagnostics has made no investments or acquisitions yet.
Reports related to Metabolomic Diagnostics
Here is the latest report on Metabolomic Diagnostics's sector:
News related to Metabolomic Diagnostics
•
•
Trinity acquires preeclampsia test developer MetabolomicsSeeking Alpha•Sep 24, 2024•Trinity Biotech, Metabolomic Diagnostics
•
•
Metabolomic Diagnostics Secures €2m EU FundingBusiness Plus•May 15, 2018•Metabolomic Diagnostics, Europa
•
Are you a Founder ?
FAQs about Metabolomic Diagnostics
Explore our recently published companies
- Kas Business - Noida based, 2014 founded, Unfunded company
- ArifaLab - Nairobi based, 2023 founded, Unfunded company
- TruHypothesys - Bengaluru based, 2024 founded, Unfunded company